Literature DB >> 21163318

Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks in mice.

Julie Vignisse1, Harry W M Steinbusch, Alexei Bolkunov, Joao Nunes, Ana Isabel Santos, Christian Grandfils, Sergei Bachurin, Tatyana Strekalova.   

Abstract

Pre-clinical and clinical studies on dimebon (dimebolin or latrepirdine) have demonstrated its use as a cognitive enhancer. Here, we show that dimebon administered to 3-month-old C57BL6N mice 15 min prior to training in both appetitive and inhibitory learning tasks via repeated (0.1 mg/kg) and acute (0.5 mg/kg) i.p. injections, respectively, increases memory scores. Acute treatment with dimebon was found to enhance inhibitory learning, as also shown in the step-down avoidance paradigm in 7-month-old mice. Bolus administration of dimebon did not affect the animals' locomotion, exploration or anxiety-like behaviour, with the exception of exploratory behaviour in older mice in the novel cage test. In a model of appetitive learning, a spatial version of the Y-maze, dimebon increased the rate of correct choices and decreased the latency of accessing a water reward after water deprivation, and increased the duration of drinking behaviour during training/testing procedures. Repeated treatment with dimebon did not alter the behaviours in other tests or water consumption. Acute treatment of water-deprived and non-water-deprived mice with dimebon also did not affect their water intake. Our data suggest that dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory tasks in mice.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21163318     DOI: 10.1016/j.pnpbp.2010.12.007

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  17 in total

1.  The age-related gliosis and accompanying deficit in spatial learning are unaffected by dimebon.

Authors:  Thelma R Cowley; Rodrigo Esteban González-Reyes; Jill C Richardson; David Virley; Neil Upton; Marina A Lynch
Journal:  Neurochem Res       Date:  2012-09-26       Impact factor: 3.996

Review 2.  Novel Sites of Neuroprotective Action of Dimebon (Latrepirdine).

Authors:  Aleksey Ustyugov; Elena Shevtsova; Sergey Bachurin
Journal:  Mol Neurobiol       Date:  2015-06-30       Impact factor: 5.590

3.  Resilience in Aging Mice.

Authors:  James L Kirkland; Michael B Stout; Felipe Sierra
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2016-08-16       Impact factor: 6.053

Review 4.  Mitochondrial dysfunction--a pharmacological target in Alzheimer's disease.

Authors:  Gunter P Eckert; Kathrin Renner; Schamim H Eckert; Janett Eckmann; Stephanie Hagl; Reham M Abdel-Kader; Christopher Kurz; Kristina Leuner; Walter E Muller
Journal:  Mol Neurobiol       Date:  2012-05-03       Impact factor: 5.590

5.  Latrepirdine (dimebon) enhances autophagy and reduces intracellular GFP-Aβ42 levels in yeast.

Authors:  Prashant R Bharadwaj; Giuseppe Verdile; Renae K Barr; Veer Gupta; John W Steele; M Lenard Lachenmayer; Zhenyu Yue; Michelle E Ehrlich; Gregory Petsko; Shulin Ju; Dagmar Ringe; Sonia E Sankovich; Joanne M Caine; Ian G Macreadie; Sam Gandy; Ralph N Martins
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

6.  Dimebon alters hippocampal amyloid pathology in 3xTg-AD mice.

Authors:  Sylvia E Perez; Muhammad Nadeem; Katherine R Sadleir; Joanna Matras; Christy M Kelley; Scott E Counts; Robert Vassar; Elliott J Mufson
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2012-09-20

7.  Pro-neurogenic, Memory-Enhancing and Anti-stress Effects of DF302, a Novel Fluorine Gamma-Carboline Derivative with Multi-target Mechanism of Action.

Authors:  Tatyana Strekalova; Nataliia Bahzenova; Alexander Trofimov; Angelika G Schmitt-Böhrer; Nataliia Markova; Vladimir Grigoriev; Vladimir Zamoyski; Tatiana Serkova; Olga Redkozubova; Daria Vinogradova; Alexei Umriukhin; Vladimir Fisenko; Christina Lillesaar; Elena Shevtsova; Vladimir Sokolov; Alexey Aksinenko; Klaus-Peter Lesch; Sergey Bachurin
Journal:  Mol Neurobiol       Date:  2018-01       Impact factor: 5.590

Review 8.  Update in the methodology of the chronic stress paradigm: internal control matters.

Authors:  Tatyana Strekalova; Yvonne Couch; Natalia Kholod; Marco Boyks; Dmitry Malin; Pierre Leprince; Harry Mw Steinbusch
Journal:  Behav Brain Funct       Date:  2011-04-27       Impact factor: 3.759

9.  Differential involvement of the gamma-synuclein in cognitive abilities on the model of knockout mice.

Authors:  Viktor S Kokhan; Gennadiy I Van'kin; Sergey O Bachurin; Inna Yu Shamakina
Journal:  BMC Neurosci       Date:  2013-05-14       Impact factor: 3.288

Review 10.  A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions.

Authors:  Anil Kumar; Arti Singh
Journal:  Front Pharmacol       Date:  2015-09-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.